Arabic Arabic English English French French German German
dark

Stakeholder Call: COVID-19 Therapeutics

Dr. Patrizia Cavazzoni, director for the Center for Drug Evaluation and Research, and Dr. John Farley, director of the Office of Infectious Diseases at FDA share information on the three recently authorized COVID-19 drug products. Dr. Jason Roos, the new COO of the HHS Coordination Operations and Response Element, which resides in the Assistant Secretary for Preparedness and Response, discusses the allocation and distribution of United States Government purchased COVID-19 drug products.

Sharing a link to the COVID-19 Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

What is Hashimoto’s disease?

Next Post

Novel hydrogel promotes neural regeneration after spinal cord injury

Related Posts
Total
0
Share